NEW YORK (GenomeWeb News) — OncoMethylome will use BioTrove’s OpenArray PCR screening technology to develop gene-methylation cancer biomarkers, BioTrove said today.
 
Terms of the multi-year supply agreement call for BioTrove to provide its OpenArray nanoplates and instruments to help OncoMethylome study and develop DNA methylation-based biomarkers, BioTrove said.
 
OncoMethylome focuses on detecting cancer cells and using PCR tests to predict their response to treatments.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.